RxDoctor Payments Data

Heather Hughes

Psychiatric/Mental Health · Tampa, FLNPI 1538697511

Payments from drug & device makers

$4,383in general payments, 2019–2025

Across 216 payments — averaging $20.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$876
  • Neurocrine Biosciences, Inc.$497
  • Otsuka America Pharmaceutical, Inc.$438
  • Axsome Therapeutics, Inc.$334
  • Alkermes, Inc.$275
  • Neuronetics, Inc.$223
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$4,383100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,383 in reported general payments places this provider in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$30,224
Medicare patients
27
Services billed
362

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine12$1,036
Desvenlafaxine Succinate ErDesvenlafaxine Succinate35$888
Bupropion XlBupropion Hcl58$796
Lamotrigine17$594
Aripiprazole27$550
Hydroxyzine Hcl12$380
Naltrexone Hcl12$363
Bupropion Hcl SrBupropion Hcl11$292
Quetiapine Fumarate15$285
Clonazepam35$242
Buspirone Hcl22$225
Trazodone Hcl46$220
Escitalopram Oxalate20$198
Sertraline Hcl21$171
Fluoxetine Hcl22$78

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Almatica Pharma LLCSertraline Hcl$190$17121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →